Abstract
There is a controversy regarding whether there are thyrotropin (TSH) receptors in orbital fat and eye muscle tissues that may play a role in the pathogenesis of Graves’ ophthalmopathy. To elucidate whether there are TSH receptors in orbital fat and eye muscle tissues in patients with Graves’ ophthalmopathy, we applied the method of in situ hybridization in orbital fat and eye muscle tissues obtained during the operation for patients with Graves’ ophthalmopathy, to directly detect TSH receptor mRNA. To identify whether the cells with positive TSH receptor mRNA are fibroblasts, we also did vimentin immunoreactivity study. To further prove the transcript does have a full length of TSH receptor, the samples of total RNA preparations, extracted from orbital fat and eye muscle tissues, were used as a template for reverse transcriptase polymerase chain reaction (RT-PCR) using three primer sets to generate cDNA fragments and cloned for sequencing. The results showed that the expression of TSH receptor mRNA was demonstrated in adipocytes and fibroblasts of orbital fat, and perimysial fibroblasts within eye muscle tissues by in situ hybridization and vimentin immunoreactivity study. Also, by using the RT-PCR, cloning and sequencing, we further proved that the transcript does have a full length of TSH receptor. The present study suggested that there are TSH receptors expressed in orbital fat and eye muscle tissues.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Rees Smith B., McLachlan S.M., Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr. Rev. 1988, 9: 106–121.
Bahn R.S., Heufelder A.E. Pathogenesis of Graves’ ophthalmopathy. N. Engl. J. Med. 1993, 20: 1468–1475.
Tsao M., Ferrarini M., Evans C., Ambro A., Whiteside T.L. Purification of a glycosaminoglycan-stimulatory lymphokine from supernatants of in vitro-activated human mononuclear cells. Clin. Immunol. Immunopathol. 1989, 50: 122–313.
Heufelder A.E., Smith T.J., Gorman C.A., Bahn R.S. Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves’ ophthalmopathy and pretibial dermopathy. J. Clin. Endocrinol. Metab. 1991, 73: 307–131.
Heufelder A.E., Dutton C.M., Sarkar G., Donovan K.A., Bahn R.S. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves’ ophthalmopathy and pretibial dermopathy. Thyroid 1993, 3: 297–300.
Mengistu M., Lukes Y.G., Nagy E.V., Burch H.B., Carr F.E., Lahiri S., Burman K.D. TSH receptor gene expression in retroocular fibroblasts. J. Endocrinol. Invest. 1994, 17: 437–441.
Hiromatsu Y., Sato M., Inoue Y., Koga M., Miyake I., Kameo J., Tokisawa S., Yang D., Nonaka K. Localization and clinical significance of thyrotropin receptor mRNA expression in orbital fat and eye muscle tissues from patients with thyroid-associated ophthalmopathy. Thyroid 1996, 6: 553–562.
Chang T.C., Wu S.L., Hsiao Y.L., Kuo S.T., Chien L.F., Kuo Y.F., Chang C.C., Chang T.J. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor. Clin. Immunol. Immunopathol. 1994, 71: 113–120.
Feliciello A., Porcellini A., Ciullo I., Bonavolonta G., Avvedimento E.V., Fenzi G. Expression of thyrotropin-receptor mRNA in healthy and Graves’ disease retro-orbital tissue. Lancet 1993, 342: 337–338.
Paschke R., Elisei R., Vassart G., Ludgate M. Lack of evidence supporting the presence of mRNA for the thyrotropin receptor in extraocular muscle. J. Endocrinol. Invest. 1993, 16: 329–332.
Wu S.L., Chang T.C., Chang T.J., Kuo Y.F., Hsiao Y.L., Chang C.C. Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells. J. Endocrinol. Invest. 1996, 19: 365–370.
Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162: 156–159.
Nagayama Y., Kaufman K.D., Seto P., Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem. Biophys. Res. Commun. 1989, 165: 1184–1190.
Bahn R.S., Dutton C.M., Heufelder A.E., Sarkar G. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 1994, 78: 256–260.
Frazier A.L., Robbins L.S., Stork P.J., Sprengel R., Segaloff D.L., Cone R.D. Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing. Mol. Endocrinol. 1990, 4: 1264–1276.
Libert F., Lefort A., Gerard C., Parmentier M., Perret J., Ludgate M., Dumont J.E., Vassart G. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem. Biophys. Res. Commun. 1989, 165: 1250–1255.
Misrahi M., Loosfelt H., Atger M., Sar S., Guiochon-Mantel A., Milgrom E. Cloning, sequencing and expression of human TSH receptor. Biochem. Biophys. Res. Commun. 1990, 166: 394–403.
Burch H.B., Sellitti D., Arnes S.G., Nagy E.V., Bahn R.S., Burman K.D. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 1994, 78: 1384–1391.
Heufelder A.E. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves’ ophthalmopathy. Thyroid 1995, 5: 331–340.
Spitzweg C., Joba W., Hunt N., Heufelder A.E. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue. Eur. J. Endocrinol. 1997, 136: 599–607.
Roselli-Rehfuss L., Robbins L.S., Cone R.D. Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig. Endocrinology 1992, 130: 1857–1861.
Iida Y., Amir S.M., Ingbar S.H. Stabilization, partial purification, and characterization of thyrotropin receptors in solubilized guinea pig fat cell membranes. Endocrinology 1975, 121: 1627–1636.
Perros P., Kendall-Taylor P. TSH-binding sites are present in orbital connective tissue and are recognized by IgG from patients with thyroid-associated ophthalmopathy. J. Endocrinol. Invest. 1994, 17: 163–170.
Bahn R.S., Dutton C.M., Natt N., Joba W., Spitzweg C., Heufelder A.E. Thyrotropin receptor expression in Graves’ orbital adipose/connective tissues: potential autoantigen in Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 1998, 83: 998–1002.
Gross B., Misrahi M., Sar S., Milgrom E. Composite structure of the human thyrotropin receptor gene. Biochem. Biophys. Res. Commun. 1991, 177: 679–687.
Major B.J., Cures A., Frauman A.G. The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: a link to the pathogenesis of Graves’ ophtahlmopathy. Biochem. Biophys. Res. Commun. 1997, 230: 493–496.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wu, S.L., Yang, C.S.J., Wang, H.J. et al. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves’ ophthalmopathy by in situ hybridization. J Endocrinol Invest 22, 289–295 (1999). https://doi.org/10.1007/BF03343558
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343558